MERTK and melanoma: Some studies have found that the expressions of Tyro3, Ax1, MERTK and their ligands of MDSCs in tumor-bearing (melanoma) mice are significantly up-regulated, which can inhibit the ability of T cells to migrate to tumor draining lymph nodes.